Detail Information
Publications
Bundled care for septic shock: an analysis of clinical trialsAmisha V Barochia
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
Crit Care Med 38:668-78. 2010..Valid bundles require effective components with additive benefits. Proponents encourage evaluation of bundles, both as a whole and based on the performance of each component...
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Building 10, Room 2C145, Bethesda, MD 20892, USA
Expert Opin Drug Metab Toxicol 7:479-94. 2011..Even if the ongoing Phase III clinical trial enrolling patients with severe sepsis and increased risk of death shows benefit from eritoran, questions remain and confirmatory studies would be necessary to define its clinical usage...
Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in caninesAmisha V Barochia
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
J Infect Dis 205:818-29. 2012..We investigated whether protective antigen-directed monoclonal antibody (PA-mAb) treatment further augments titrated hemodynamic support...
